
WuXi Biologics (Cayman) Inc.: management transactions · Hong Kong · HKEX
HKEX:wuxi-biologics-cayman-incHKHK·HKEXMcap 136.2Bn€Healthcare
Browse the full management transaction log of WuXi Biologics (Cayman) Inc., a listed equity based in Hong Kong. Shares are listed on HK HK, under the authority of HKEX. Operating in the Healthcare sector, WuXi Biologics (Cayman) Inc. has logged 7 insider filings. Market capitalisation: €136.2bn. The latest transaction was disclosed on 2 April 2026 (Other). Among the most active insiders: Gu Sherry Xuejun. All data is accessible without an account.
Financial data
FY ended December 2025 · cache
Analyst consensus
21 analysts ·30.43 €Target 46.20 €(+40%)78.02 €
Income statement
Revenue21.79 Bn€
Gross profit10.02 Bn€46% margin
Net income4.91 Bn€22.5% margin
Valuation
PER (trailing)24.6x
PER (forward)19.3x
P/Book2.5x
Beta0.58
Balance sheet & cash
Market cap136.16 Bn€
Total debt3.10 Bn€
Free Cash Flow2.61 Bn€
Debt / Equity6%
Profitability & ownership
ROE11.6%
ROA6.9%
% insiders10.0%
% institutions35.7%
Last declaration on 2 April 2026